- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Price not available for CSRMF:US
Snapshot for Consort Medical PLC (CSRMF)
| Open: | - | Day's Range: | - | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 11.6000 | 52wk Range: | 11.6000 - 11.6687 | 1-Yr Rtn: | - |
Key Statistics for CSRMF
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(04/2014) | 16.6117 |
| Relative P/E vs. SPX | - |
| Earnings Per Share (GBP) (ttm) | - |
| Est. EPS (GBP) (04/2014) | 0.4460 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 2.98% |
| Cash Dividend (GBp) | 12.7100 |
| Last Dividend | 09/18/2013 |
| 5 Year Dividend Growth | -4.24% |
| Next Earnings Announcement | 12/05/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CSRMF
Company Profile & Key Executives for CSRMF
Consort Medical PLC supplies drug delivery devices and development services to pharmaceutical companies. The Company develops and manufactures metered dose inhaler valves actuators, compliance-aids, dry powder devices, disposable face masks, breathing circuits and laryngeal tubes.
| Jonathan GlennChief Executive Officer | Richard CottonGroup Finance Dir/Exec Dir |
| John Andrew Duncan SlaterSecretary/General Counsel |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CSRMF News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page